As written in the abstract of the Journal of Nutrition publication:
A Meta-Analysis Shows That Docosahexaenoic Acid? from Algal Oil Reduces Serum Triglycerides and Increases HDL-Cholesterol and LDL-Cholesterol in Persons without Coronary Heart Disease
Adam M. Bernstein, Eric L. Ding, Walter C. Willett and Eric B. Rimm
Certain algae contain the (n-3) fatty acid DHA, yet the relation between algal oil supplementation and cardiovascular disease risk factors has not been systematically examined.
Our objective was to examine the relation between algal oil supplementation and cardiovascular disease risk factors. We conducted a systematic review of randomized controlled trials published between 1996 and 2011 examining the relation between algal oil supplementation and cardiovascular disease risk factors and performed a meta-analysis of the association between algal oil DHA supplementation and changes in the concentrations of TG, LDL-cholesterol (LDL-C), and HDL-cholesterol (HDL-C).
We identified 11 randomized controlled trials with 485 healthy participants that evaluated the relation between algal oil DHA supplementation and TG, LDL-C, and HDL-C.
DHA supplementation from algal oil, a marine source of (n-3) fatty acids not extracted from fish, may reduce serum TG and increase HDL-C and LDL-C in persons without coronary heart disease.
Leading UK?Nutritionist at Foods for Life Health and Nutrition in Harley Street, London Yvonne Bishop-Weston said, “Triglyceride imbalances?are a factor in a number of chronic diseases so it’s good to have some meta analysis to back up our findings in clinic that Omega 3 DHA can make a difference as part of an optimal health strategy”